Skip to content

Bispectral Index Monitoring During Testing in the Electrophysiology Lab

To Assess the Utility of BIS Monitoring in the Administration of Moderate Sedation in Patients Undergoing Implantable Cardioverter -Defibrillator (ICD) Implantation With Defibrillatory Threshold (DFT) Testing

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00749671
Enrollment
20
Registered
2008-09-09
Start date
2007-10-31
Completion date
2013-08-31
Last updated
2016-10-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tachycardia, Ventricular

Brief summary

BACKGROUND Physician-guided moderate sedation, administered by a Registered Nurse has been the standard of practice for patients undergoing a wide range of electrophysiology procedures during the past decade. Currently a subjective sedation assessment tool is the standard of practice within the Electrophysiology Lab (EP Lab). Bispectral Index monitoring (BIS) is an objective measure of the depth of sedation presently employed at Baystate Medical Center in the Intensive Care Unit and within the department of anesthesia. AIM The aim of this research study is to assess the utility of BIS monitoring in measuring the depth of sedation in patients undergoing defibrillation threshold testing (DFT). Our primary endpoint is: A change in OAAS scores of one point at the 30 minute data collection time period. Our secondary endpoints are: Lack of explicit recall of DFT testing and measurement of perioperative level of comfort. STUDY DESIGN AND SCOPE The population to be studied is those patients receiving a primary ICD implant or an ICD battery change with defibrillation threshold testing (DFT). All patients who have consented for ICD placement and DFT testing with moderate sedation will be invited to participate in this research study. Patients who are not candidates for DFT testing, as is determined by the EP physician, will be excluded from the study. Demographic data including: age, gender, BMI, current medications and history of sleep apnea will be collected. Data detailing the amount of drug administered during the procedure and any use of reversal agents, will be retrieved from the medical record. The study will be conducted within the Electrophysiology lab at Baystate Medical Center. An enrollment of 60 subjects is expected to be completed within 6 months. 30 patients will originate from the outpatient population and 30 from the inpatient. Follow up assessments using the OAAS scale will be completed at 30 min, 1 hour and 4 hours post procedure. Also, perioperative comfort and recall of DFT testing will be assessed at the 4 hour mark.

Detailed description

BACKGROUND Physician-guided moderate sedation, administered by a Registered Nurse has been the standard of practice for patients undergoing a wide range of electrophysiology procedures during the past decade. Currently a subjective sedation assessment tool is the standard of practice within the Electrophysiology Lab (EP Lab). Bispectral Index monitoring (BIS) is an objective measure of the depth of sedation presently employed at Baystate Medical Center in the Intensive Care Unit and within the department of anesthesia. AIM The aim of this research study is to assess the utility of BIS monitoring in measuring the depth of sedation in patients undergoing defibrillation threshold testing (DFT). Our primary endpoint is: A change in Observer's Assessment of Alertness/Sedation Scales (OAAS) scores of one point at the 30 minute data collection time period. Our secondary endpoints are: Lack of explicit recall of DFT testing and measurement of perioperative level of comfort. STUDY DESIGN AND SCOPE The population to be studied is those patients receiving a primary ICD implant or an ICD battery change with defibrillation threshold testing (DFT). All patients who have consented for ICD placement and DFT testing with moderate sedation will be invited to participate in this research study. Patients who are not candidates for DFT testing, as is determined by the EP physician, will be excluded from the study. Demographic data including: age, gender, BMI, current medications and history of sleep apnea will be collected. Data detailing the amount of drug administered during the procedure and any use of reversal agents, will be retrieved from the medical record. The study will be conducted within the Electrophysiology lab at Baystate Medical Center. An enrollment of 60 subjects is expected to be completed within 6 months. 30 patients will originate from the outpatient population and 30 from the inpatient. Follow up assessments using the OAAS scale will be completed at 30 min, 1 hour and 4 hours post procedure. Also, perioperative comfort and recall of DFT testing will be assessed at the 4 hour mark.

Interventions

The monitoring of the EEG signal is designed to determine if the sedation is adequate.

The determination of the degree of sedation is accomplished using an established sedation scale.

Sponsors

Baystate Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* All patients who are having ICD placement and DFT testing will be invited to participate in this research study.

Exclusion criteria

* Patients who are not candidates for DFT testing, as is determined by the EP physician * An example of such a patient would be one who is hemodynamically unstable; * DFT testing is contraindicated in this case.

Design outcomes

Primary

MeasureTime frameDescription
Observer's Assessment of Alertness/Sedation (OAAS) Rating Scale at 30 Minutes30 minutesSedation level was evaluated and graded according to the observer's assessment of alertness/sedation (OAAS) rating scale. This scale has 6 possible measures of consciousness: OAAS score 5-awake and responds readily to name spoken in normal tone. OAAS score 4-lethargic responses to name in normal tone. OAAS score 3-responds only after name is called loudly and/or repeatedly. OAAS score 2-responds only after name called loudly and mild shaking. OAAS score 1-does not respond when name is called loudly and mild shaking or prodding. OAAS score 0-does not respond to noxious stimulation.

Secondary

MeasureTime frameDescription
Patient Recall of Defibrillation Testing30 minutesThe patient recall of the testing will be assessed at 30 minutes, as answered with a yes/no.

Countries

United States

Participant flow

Participants by arm

ArmCount
ICD Testingwith Bispectral Monitoring
Bispectral Index Monitoring Bispectral index monitoring using Aspect Monitor: The monitoring of the EEG signal is designed to determine if the sedation is adequate.
11
Nurse Administered Moderate Sedation
Moderate sedation using the Ramsey scale as assessed by a nurse trained and dedicated to monitoring the patient
9
Total20

Baseline characteristics

CharacteristicICD Testingwith Bispectral MonitoringNurse Administered Moderate SedationTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
11 Participants9 Participants20 Participants
Region of Enrollment
United States
11 participants9 participants20 participants
Sex: Female, Male
Female
NA ParticipantsNA ParticipantsNA Participants
Sex: Female, Male
Male
NA ParticipantsNA ParticipantsNA Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 110 / 9
serious
Total, serious adverse events
0 / 110 / 9

Outcome results

Primary

Observer's Assessment of Alertness/Sedation (OAAS) Rating Scale at 30 Minutes

Sedation level was evaluated and graded according to the observer's assessment of alertness/sedation (OAAS) rating scale. This scale has 6 possible measures of consciousness: OAAS score 5-awake and responds readily to name spoken in normal tone. OAAS score 4-lethargic responses to name in normal tone. OAAS score 3-responds only after name is called loudly and/or repeatedly. OAAS score 2-responds only after name called loudly and mild shaking. OAAS score 1-does not respond when name is called loudly and mild shaking or prodding. OAAS score 0-does not respond to noxious stimulation.

Time frame: 30 minutes

ArmMeasureValue (MEAN)
ICD TestingObserver's Assessment of Alertness/Sedation (OAAS) Rating Scale at 30 Minutes4.27 units on a scale
ICD testing2Observer's Assessment of Alertness/Sedation (OAAS) Rating Scale at 30 Minutes4.33 units on a scale
Secondary

Patient Recall of Defibrillation Testing

The patient recall of the testing will be assessed at 30 minutes, as answered with a yes/no.

Time frame: 30 minutes

ArmMeasureValue (NUMBER)
ICD TestingPatient Recall of Defibrillation Testing0 percentage of patients with DFT recall
ICD testing2Patient Recall of Defibrillation Testing0 percentage of patients with DFT recall

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026